The revenue stands at ₹62.94 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.54 per cent from ₹62.60 crore. This corresponds to a year-on-year *(YoY) growth of 56.49 per cent.
Operating Profit stands at ₹5.71 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 29.33 per cent from ₹8.08 crore. This corresponds to a year-on-year *(YoY) growth of 33.41 per cent.
PBDT stands at ₹5.21 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 28.63 per cent from ₹7.30 crore. This corresponds to a year-on-year *(YoY) growth of 60.80 per cent.
Profit Before Tax stands at ₹3.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.50 per cent from ₹5.20 crore. This corresponds to a year-on-year *(YoY) growth of 124.14 per cent.
Net Profit stands at ₹2.71 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 25.14 per cent from ₹3.62 crore. This represents a 123.97 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Parnax Lab | 1.89% | 5.13% | 37.23% | 37.11% | 25.53% | 58.51% |
| Oxygenta Pharma | 0.00% | 2.42% | 23.01% | -2.29% | -0.51% | -21.46% |
| Lyka Labs | -0.93% | 1.56% | 17.09% | -19.42% | -39.61% | -49.55% |
| Sanjiv.Parant. | -4.55% | -6.77% | 12.71% | -6.61% | -18.90% | -32.99% |
| Brooks Lab. | -2.34% | -10.71% | 34.84% | -5.36% | -48.75% | -55.44% |
| Kimia Bioscien. | -1.36% | -1.83% | 32.11% | 23.26% | 11.21% | -14.63% |
| Astonea Labs | 0.61% | 5.81% | 6.84% | 5.81% | 3.14% | 20.90% |
ED / MD / CEO / Promoter : Mihir Prakash Shah
Director & CFO : Binoy Baiju Shah
Non-Exec & Non-Independent Dir : Ami M Shah
Independent Non Exe. Director : Yogesh Varia
Independent Non Exe. Director : Harish S Panpalia
Independent Non Exe. Director : Vijay Kumar Ayare
Company Sec. & Compli. Officer : Preet Kukreja